Australia markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2400-0.0700 (-2.11%)
At close: 04:00PM EDT
3.3000 +0.06 (+1.85%)
After hours: 05:36PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-0.04-0.03-0.110.01
Low estimate-0.05-0.05-0.17-0.05
High estimate-0.02-0.01-0.030.06
Year ago EPS-0.35-0.17-0.8-0.11
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate35.89M36.92M147.85M177.92M
Low estimate34.75M35.7M142.82M175M
High estimate37.5M39.3M153.2M182.9M
Year ago sales31.76M31.43M127.04M147.85M
Sales growth (year/est)13.00%17.50%16.40%20.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.23-0.29-0.16-0.09
Actual EPS-0.35-0.17-0.07-0.02
Difference-0.120.120.090.07
Surprise %-52.20%41.40%56.20%77.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.04-0.03-0.110.01
7 days ago-0.04-0.03-0.110.01
30 days ago-0.04-0.03-0.110.01
60 days ago-0.04-0.03-0.110.01
90 days ago-0.07-0.06-0.45-0.36
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesHRTXIndustrySector(s)S&P 500
Current qtr.88.60%N/AN/AN/A
Next qtr.82.40%N/AN/AN/A
Current year86.20%N/AN/AN/A
Next year109.10%N/AN/AN/A
Next 5 years (per annum)47.50%N/AN/AN/A
Past 5 years (per annum)-43.36%N/AN/AN/A